PGEN

PRECIGEN, INC.

Nasdaq · Pharmaceutical Preparations · Inc. VA · CIK 0001356090
$3.57 -0.28% $1.3B
Insider Selling Cluster (5 insiders)High Impact Filing (7/10)3 New Institutional Positions
Vol
Market Cap$1.3B
Cap SizeSmall Cap
Analyst ConsensusStrong Buy (78%)
Inst. Holders6 funds
Inst. Value$93.4M
Inst. Activity3 buys / 0 sells
Insider Activity0B / 6S
Insider Net $-$4.8M
Reddit Sentiment60° Warm
SEC Reports4
Exchange Nasdaq·Sector Pharmaceutical Preparations·Inc. VA·CIK 0001356090·Prev Close $3.58

Recent Activity

Jun 1, 2026 SEC
Four top executives at Precigen (CEO, CFO, COO, CLO) sold a combined $1.02M in open-market sales on May 28, 2026, all at
CLUSTER — Impact 3/10
Jun 1, 2026 SEC
Three top executives at Precigen (CEO, COO, CLO) sold a combined $833K in open-market sales on May 28, 2026, at $4.36/sh
CLUSTER — Impact 3/10
Jun 1, 2026 short_volume
Short Volume: PGEN — 59.8% short (1.0M / 1.7M)
Short: 1,003,593 | Exempt: 5,544 | TRF Vol: 1,678,067 | Short Ratio: 59.8% | Off-exchange volume (da
May 28, 2026 Insider
Sabzevari Helen sold 119,250 shares
President and CEO @ $4.36 ($519.9K)
May 28, 2026 Insider
Shah Rutul R sold 42,703 shares
Chief Operating Officer @ $4.36 ($186.2K)
May 28, 2026 Insider
Lehr Donald P. sold 29,131 shares
Chief Legal Officer @ $4.36 ($127.0K)
May 13, 2026 SEC
Precigen reported Q1 2026 revenue of $23.3M, massively up from $1.3M a year ago, driven by $21.6M in PAPZIMEOS product r
8-K — Impact 7/10
Inst.
FMR LLC — DOUBLED
4,652,179 shares ($19.4M)

Price Targets

$12.45 +235.6% upside Strong Buy
Current $3.71 Low $11.00 Median $12.45 High $13.90 2 analysts
$11.00 $13.90

Analyst Ratings

Buy78% buy · 9 analysts
2Strong Buy
5Buy
2Hold
0Sell
0Strong Sell
Recent Analyst Actions
DateFirmActionRating
May 28, 2026 HC Wainwright & Co. MAINTAIN Buy → Buy
May 14, 2026 Citizens MAINTAIN Market Outperform → Market Outperform
May 14, 2026 HC Wainwright & Co. MAINTAIN Buy → Buy
Mar 26, 2026 Citizens MAINTAIN Market Outperform → Market Outperform
Mar 26, 2026 HC Wainwright & Co. MAINTAIN Buy → Buy

Earnings Estimates

PeriodEPS Est.RangeGrowth#
Current Q $-0.01 ▲ +59.5% $-0.02 — $-0.01 87% YoY 3
Next Q $-0.00 ▲ +88.6% $-0.01 — $0.01 100% YoY 3
Current FY $-0.03 ▲ +71.2% $-0.06 — $0.02 98% YoY 3
Next FY $0.20 ▲ +266.1% $0.09 — $0.34 799% YoY 3

Top Institutional Holders

FundValueMove
VANGUARD GROUP INC$43.8M
FMR LLC$19.4MDOUBLED
MORGAN STANLEY$13.3MADD
BANK OF AMERICA CORP$9.1MDOUBLED
CHARLES SCHWAB INVESTMENT MANAGEMENT$6.3MNEW

Recent Insider Trades

DateInsiderTypeValue
May 28, 2026Sabzevari HelenSELL$519.9K
May 28, 2026Shah RutulSELL$186.2K
May 28, 2026Lehr DonaldSELL$127.0K
May 28, 2026Thomasian HarrySELL$182.6K
May 28, 2026Tennant PhilSELL$132.0K

Reddit Sentiment

60°
Warm
Bearish Neutral Bullish
6 mentions 2 bullish 0 bearish
6 institutional holders with $93.4M total value (22,346,867 shares) as of 2025-Q4. Top holders: VANGUARD, FMR, MORGAN. Net buying activity: 3 institutions added/increased vs 0 reduced.

Top Institutional Holders — 2025-Q4

#FundSharesValue% of TrackedLast Move
1VANGUARD GROUP INC10,479,452$43.8M46.9%
2FMR LLC4,652,179$19.4M20.8%DOUBLED +3887.7%
3MORGAN STANLEY3,193,523$13.3M14.3%ADD +61.2%
4BANK OF AMERICA CORP /DE/2,188,606$9.1M9.8%DOUBLED +201.1%
5CHARLES SCHWAB INVESTMENT MANAGEMENT INC1,506,755$6.3M6.7%NEW
6WELLS FARGO & COMPANY/MN326,352$1.4M1.5%ADD +68.3%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
FMR LLCDOUBLED116,6624,652,179+3887.7%$19.4M2025-Q4
MORGAN STANLEYADD1,981,6443,193,523+61.2%$13.3M2025-Q4
WELLS FARGO & COMPANY/MNADD193,860326,352+68.3%$1.4M2025-Q4
BANK OF AMERICA CORP /DE/DOUBLED832,2612,505,992+201.1%$8.2M2025-Q3
UBS Group AGADD356,395630,604+76.9%$2.1M2025-Q3
FMR LLCTRIM334,241116,662-65.1%$383.8K2025-Q3
RENAISSANCE TECHNOLOGIES LLCEXIT287,4030-100.0%$0.002025-Q3
MORGAN STANLEYADD1,033,1102,040,974+97.6%$2.9M2025-Q2
BANK OF AMERICA CORP /DE/DOUBLED232,347832,261+258.2%$1.2M2025-Q2
UBS Group AGTRIM512,307356,395-30.4%$506.1K2025-Q2
RENAISSANCE TECHNOLOGIES LLCTRIM792,803287,403-63.7%$408.1K2025-Q2
RENAISSANCE TECHNOLOGIES LLCTRIM1,067,645792,803-25.7%$1.2M2025-Q1
WELLS FARGO & COMPANY/MNADD114,558146,456+27.8%$218.2K2025-Q1
CITADEL ADVISORS LLCADD76,200117,500+54.2%$175.1K2025-Q1
RENAISSANCE TECHNOLOGIES LLCTRIM1,600,1901,067,645-33.3%$1.2M2024-Q4
UBS Group AGDOUBLED99,524421,240+323.3%$471.8K2024-Q4
CITADEL ADVISORS LLCNEAR_EXIT497,79976,200-84.7%$85.3K2024-Q4
CHARLES SCHWAB INVESTMENT MANAGEMENT INCNEW1,222,850$1.2M2024-Q3
12 unique insiders with 6 transactions. Net insider value: -$4.8M ($0.00 bought, $4.8M sold).

Insider Transactions

DateInsiderTitleTypeSharesPriceValue
May 28, 2026Sabzevari HelenPresident and CEOSELL119,250$4.36$519.9K
May 28, 2026Shah Rutul RChief Operating OfficerSELL42,703$4.36$186.2K
May 28, 2026Lehr Donald P.Chief Legal OfficerSELL29,131$4.36$127.0K
May 28, 2026Thomasian Harry Jr.Chief Financial OfficerSELL41,884$4.36$182.6K
May 28, 2026Tennant PhilChief Commercial OfficerSELL30,272$4.36$132.0K
May 23, 2026Lehr Donald P.Chief Legal OfficerM62,500$0.00$0.00
May 23, 2026Lehr Donald P.Chief Legal OfficerM62,500$0.00$0.00
May 23, 2026Sabzevari HelenPresident and CEOM250,000$0.00$0.00
May 23, 2026Sabzevari HelenPresident and CEOM250,000$0.00$0.00
May 23, 2026Shah Rutul RChief Operating OfficerM90,000$0.00$0.00
May 23, 2026Shah Rutul RChief Operating OfficerM90,000$0.00$0.00
May 23, 2026Tennant PhilChief Commercial OfficerM62,500$0.00$0.00
May 23, 2026Tennant PhilChief Commercial OfficerM62,500$0.00$0.00
May 23, 2026Thomasian Harry Jr.Chief Financial OfficerM87,500$0.00$0.00
May 23, 2026Thomasian Harry Jr.Chief Financial OfficerM87,500$0.00$0.00
Apr 20, 2026Thomasian Harry Jr.Chief Financial OfficerA399,000$0.00$0.00
Apr 20, 2026Thomasian Harry Jr.Chief Financial OfficerA120,000$0.00$0.00
Apr 20, 2026Tennant PhilChief Commercial OfficerA385,000$0.00$0.00
Apr 20, 2026Tennant PhilChief Commercial OfficerA115,000$0.00$0.00
Apr 20, 2026Sabzevari HelenPresident and CEOA410,000$0.00$0.00
Apr 20, 2026Shah Rutul RChief Operating OfficerA395,000$0.00$0.00
Apr 20, 2026Shah Rutul RChief Operating OfficerA118,000$0.00$0.00
Apr 20, 2026Sabzevari HelenPresident and CEOA1,366,000$0.00$0.00
Apr 20, 2026Lehr Donald P.Chief Legal OfficerA358,000$0.00$0.00
Apr 20, 2026Lehr Donald P.Chief Legal OfficerA107,000$0.00$0.00
Mar 30, 2026KIRK RANDAL JDirectorSELL1,108,998$3.30$3.7M
Mar 18, 2026Lehr Donald P.Chief Legal OfficerA40,443$0.00$0.00
Mar 18, 2026Lehr Donald P.Chief Legal OfficerM40,443$0.00$0.00
Mar 18, 2026Shah Rutul RChief Operating OfficerM44,495$0.00$0.00
Mar 18, 2026Sabzevari HelenPresident and CEOM321,100$0.00$0.00
Mar 18, 2026Sabzevari HelenPresident and CEOM321,100$0.00$0.00
Mar 18, 2026Tennant PhilChief Commercial OfficerA42,110$0.00$0.00
Mar 18, 2026Tennant PhilChief Commercial OfficerM42,110$0.00$0.00
Mar 18, 2026Shah Rutul RChief Operating OfficerA44,495$0.00$0.00
Mar 18, 2026Lehr Donald P.Chief Legal OfficerM40,443$0.00$0.00
Mar 18, 2026Shah Rutul RChief Operating OfficerM44,495$0.00$0.00
Mar 18, 2026Thomasian Harry Jr.Chief Financial OfficerM40,293$0.00$0.00
Mar 18, 2026Sabzevari HelenPresident and CEOA321,100$0.00$0.00
Mar 18, 2026Tennant PhilChief Commercial OfficerM42,110$0.00$0.00
Mar 18, 2026Thomasian Harry Jr.Chief Financial OfficerA40,293$0.00$0.00
Mar 18, 2026Thomasian Harry Jr.Chief Financial OfficerM40,293$0.00$0.00
Mar 13, 2026AGEE NANCY HDirectorM71,839$0.00$0.00
Mar 13, 2026Hassan FredDirectorM71,839$0.00$0.00
Mar 13, 2026Turley James SDirectorM71,839$0.00$0.00
Mar 13, 2026Gupta Vinita DDirectorM71,839$0.00$0.00
Mar 13, 2026Frank StevenDirectorM71,839$0.00$0.00
Mar 13, 2026Turley James SDirectorM71,839$0.00$0.00
Mar 13, 2026KINDLER JEFFREY BDirectorM71,839$0.00$0.00
Mar 13, 2026Gupta Vinita DDirectorM71,839$0.00$0.00
Mar 13, 2026KINDLER JEFFREY BDirectorM71,839$0.00$0.00

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Current analyst consensus: Buy (78% buy). Based on 9 analysts: 2 strong buy, 5 buy, 2 hold, 0 sell, 0 strong sell.

Analyst Price Targets

$12.45 mean target +235.6% upside Strong Buy (2.00)
$11.00 Low $13.90 High
MetricValue
Current Price$3.71
Target Low$11.00
Target Mean$12.45
Target Median$12.45
Target High$13.90
# Analysts2
RecommendationStrong Buy (2.00)

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
2026-06-30
$-0.01 $-0.02 $-0.01 86.5% +59.5% 1↑ 0↓ $0.0B 3151.8% 3
Next Q
2026-09-30
$-0.00 $-0.01 $0.01 99.8% +88.6% 2↑ 0↓ $0.0B 1044.9% 3
Current FY
2026-12-31
$-0.03 $-0.06 $0.02 97.9% +71.2% 2↑ 0↓ $0.1B 1183.8% 3
Next FY
2027-12-31
$0.20 $0.09 $0.34 799.4% +266.1% 2↑ 0↓ $0.2B 84.2% 3

Current Quarter EPS Revision History

TimepointEPS EstimateChange
Current$-0.012
7d ago$-0.010-0.002
30d ago$-0.030+0.018
60d ago$-0.030+0.018
90d ago$-0.055+0.043
2 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.

Individual Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
May 28, 2026 HC Wainwright & Co. MAINTAIN Buy Buy
May 14, 2026 Citizens MAINTAIN Market Outperform Market Outperform
May 14, 2026 HC Wainwright & Co. MAINTAIN Buy Buy
Mar 26, 2026 Citizens MAINTAIN Market Outperform Market Outperform
Mar 26, 2026 HC Wainwright & Co. MAINTAIN Buy Buy

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
Jun 1, 20262520078%
May 1, 20262520078%
Apr 1, 20262520078%
Mar 1, 20262520078%
Feb 1, 20262520078%
Jan 1, 20262520078%
Strong BuyBuyHoldSellStrong Sell

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

60°
Warm
Bearish Neutral Bullish
6 mentions 2 bullish 0 bearish 6 time periods

Reddit Sentiment History

DateMentionsSentimentBullishBearishThreads
May 14, 2026160° Warm101
May 14, 2026160° Warm101
May 14, 2026156° Neutral001
May 14, 2026156° Neutral001
May 14, 2026156° Neutral001
May 14, 2026156° Neutral001

Recent Reddit Threads

r/pennystocks Bullish 26d 13h ago
Precigen stock jumps after Q1 2026 beat (PGEN:NASDAQ)
▲ 1 💬 0 ⚡ 0.5
r/stocks Bullish 26d 13h ago
Is PGEN worth the price?
▲ 1 💬 1 ⚡ 0.5
r/pennystocks Bullish 27d 8h ago
PGEN- Exceeding expectations! Successful commercial launch after FDA Approval!
▲ 1 💬 1 ⚡ 0.5
Jun 1, 2026
short_volume
Short Volume: PGEN — 59.8% short (1.0M / 1.7M)
Short: 1,003,593 | Exempt: 5,544 | TRF Vol: 1,678,067 | Short Ratio: 59.8% | Off-exchange volume (dark pool + OTC)
May 29, 2026
short_volume
Short Volume: PGEN — 55.6% short (0.9M / 1.6M)
Short: 914,189 | Exempt: 0 | TRF Vol: 1,644,858 | Short Ratio: 55.6% | Off-exchange volume (dark pool + OTC)
May 15, 2026
short_volume
Short Volume: PGEN — 57.7% short (0.7M / 1.2M)
Short: 717,159 | Exempt: 16,573 | TRF Vol: 1,243,020 | Short Ratio: 57.7% | Off-exchange volume (dark pool + OTC)
May 13, 2026
earnings_calendar
PGEN Q1 2026 Earnings Scheduled — 2026-05-13
May 13, 2026
short_volume
Short Volume: PGEN — 71.5% short (0.6M / 0.9M)
Short: 647,343 | Exempt: 638 | TRF Vol: 904,818 | Short Ratio: 71.5% | Off-exchange volume (dark pool + OTC)
May 12, 2026
short_volume
Short Volume: PGEN — 57.1% short (0.6M / 1.1M)
Short: 609,590 | Exempt: 2,179 | TRF Vol: 1,067,824 | Short Ratio: 57.1% | Off-exchange volume (dark pool + OTC)
May 11, 2026
earnings_calendar
PGEN Q1 2026 Earnings Scheduled — 2026-05-11
May 8, 2026
short_volume
Short Volume: PGEN — 72.1% short (0.7M / 0.9M)
Short: 666,094 | Exempt: 10,146 | TRF Vol: 924,136 | Short Ratio: 72.1% | Off-exchange volume (dark pool + OTC)
May 7, 2026
short_volume
Short Volume: PGEN — 58.7% short (0.8M / 1.3M)
Short: 783,267 | Exempt: 0 | TRF Vol: 1,333,908 | Short Ratio: 58.7% | Off-exchange volume (dark pool + OTC)
May 6, 2026
short_volume
Short Volume: PGEN — 72.5% short (1.4M / 1.9M)
Short: 1,355,446 | Exempt: 0 | TRF Vol: 1,870,280 | Short Ratio: 72.5% | Off-exchange volume (dark pool + OTC)
May 1, 2026
short_volume
Short Volume: PGEN — 62.7% short (0.4M / 0.7M)
Short: 428,532 | Exempt: 1 | TRF Vol: 683,281 | Short Ratio: 62.7% | Off-exchange volume (dark pool + OTC)
Apr 30, 2026
short_volume
Short Volume: PGEN — 62.9% short (0.7M / 1.1M)
Short: 668,058 | Exempt: 59 | TRF Vol: 1,061,344 | Short Ratio: 62.9% | Off-exchange volume (dark pool + OTC)
Apr 28, 2026
short_volume
Short Volume: PGEN — 60.7% short (0.5M / 0.8M)
Short: 472,677 | Exempt: 25 | TRF Vol: 778,795 | Short Ratio: 60.7% | Off-exchange volume (dark pool + OTC)
Apr 27, 2026
short_volume
Short Volume: PGEN — 68.6% short (0.7M / 1.0M)
Short: 666,048 | Exempt: 196 | TRF Vol: 971,300 | Short Ratio: 68.6% | Off-exchange volume (dark pool + OTC)
Apr 22, 2026
short_volume
Short Volume: PGEN — 63.4% short (0.4M / 0.7M)
Short: 445,086 | Exempt: 604 | TRF Vol: 702,546 | Short Ratio: 63.4% | Off-exchange volume (dark pool + OTC)